Literature DB >> 25448761

Improving the predictive value of interventional animal models data.

Caroline J Zeiss1.   

Abstract

For many chronic diseases, translational success using the animal model paradigm has reached an impasse. Using Alzheimer's disease as an example, this review employs a networks-based method to assess repeatability of outcomes across species, by intervention and mechanism. Over 75% of animal studies reported an improved outcome. Strain background was a significant potential confounder. Five percent of interventions had been tested across animals and humans, or examined across three or more animal models. Positive outcomes across species emerged for donepezil, memantine and exercise. Repeatable positive outcomes in animals were identified for the amyloid hypothesis and three additional mechanisms. This approach supports in silico reduction of positive outcomes bias in animal studies.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25448761      PMCID: PMC4417064          DOI: 10.1016/j.drudis.2014.10.015

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  84 in total

Review 1.  Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.

Authors:  Meindert Danhof; Elizabeth C M de Lange; Oscar E Della Pasqua; Bart A Ploeger; Rob A Voskuyl
Journal:  Trends Pharmacol Sci       Date:  2008-03-18       Impact factor: 14.819

2.  Strain specific differences in memory and neuropathology in a mouse model of Alzheimer's disease.

Authors:  Kathryn A C Glazner; Gary L Odero; Everet Anema; Anna Motnenko; Jason Schapansky; Denise Grossman; Derek R Oliver; Gordon W Glazner; Benedict C Albensi
Journal:  Life Sci       Date:  2010-05-12       Impact factor: 5.037

3.  Should clinicians care about preclinical animal research?

Authors:  Shai D Silberberg
Journal:  Neurology       Date:  2013-03-19       Impact factor: 9.910

4.  Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Authors:  Cheryl L P Vigen; Wendy J Mack; Richard S E Keefe; Mary Sano; David L Sultzer; T Scott Stroup; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; Pierre N Tariot; Ling Zheng; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

Review 5.  New directions in toxicity testing.

Authors:  Daniel Krewski; Margit Westphal; Mustafa Al-Zoughool; Maxine C Croteau; Melvin E Andersen
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

6.  Design, power, and interpretation of studies in the standard murine model of ALS.

Authors:  Sean Scott; Janice E Kranz; Jeff Cole; John M Lincecum; Kenneth Thompson; Nancy Kelly; Alan Bostrom; Jill Theodoss; Bashar M Al-Nakhala; Fernando G Vieira; Jeyanthi Ramasubbu; James A Heywood
Journal:  Amyotroph Lateral Scler       Date:  2008

7.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Karthikeyan Veeraraghavalu; Can Zhang; Sean Miller; Jasmin K Hefendehl; Tharinda W Rajapaksha; Jason Ulrich; Mathias Jucker; David M Holtzman; Rudolph E Tanzi; Robert Vassar; Sangram S Sisodia
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

8.  Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice.

Authors:  Hiroko Koike; P Alexander Arguello; Mirna Kvajo; Maria Karayiorgou; Joseph A Gogos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-16       Impact factor: 11.205

9.  Novel microRNAs differentially expressed during aging in the mouse brain.

Authors:  Sachi Inukai; Alexandre de Lencastre; Michael Turner; Frank Slack
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  When the dust settles: what did we learn from the bexarotene discussion?

Authors:  Ina Tesseur; Bart De Strooper
Journal:  Alzheimers Res Ther       Date:  2013-11-07       Impact factor: 6.982

View more
  4 in total

1.  Immune responses to the real world.

Authors:  Caroline J Zeiss; Cory F Brayton
Journal:  Lab Anim (NY)       Date:  2017-12-29       Impact factor: 12.625

Review 2.  Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.

Authors:  Katrina Albert; Jonna Niskanen; Sara Kälvälä; Šárka Lehtonen
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease.

Authors:  Caroline J Zeiss; Heather G Allore; Amanda P Beck
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

4.  Menagerie: A text-mining tool to support animal-human translation in neurodegeneration research.

Authors:  Caroline J Zeiss; Dongwook Shin; Brent Vander Wyk; Amanda P Beck; Natalie Zatz; Charles A Sneiderman; Halil Kilicoglu
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.